Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy.

J Clin Transl Hepatol · 2022 · PMC8845160 · PMID 35233384

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

2.8 months, p =0.002), overall and progression-free survival did not reach statistical significance per specified criteria, which are consistent with the findings of KEYNOTE-224. 95 Another Checkmate 040 study 96 (phase I/II) included 148 HCC patients who had sorafenib resistance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.